A TMPRSS2-ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
Clin Transl Med
.
2020 Dec;10(8):e216.
doi: 10.1002/ctm2.216.
Authors
Emily Zhou
1
,
Baoyi Zhang
2
,
Kenneth Zhu
3
,
Evelien Schaafsma
4
,
Runjun D Kumar
5
,
Chao Cheng
6
7
8
Affiliations
1
Department of Biosciences, Rice University, Houston, Texas, USA.
2
Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas, USA.
3
UT Southwestern Medical School, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
4
Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
5
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
6
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
7
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
8
Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
PMID:
33377652
PMCID:
PMC7711082
DOI:
10.1002/ctm2.216
No abstract available
Publication types
Letter
Grants and funding
RR180061/Cancer Prevention Research Institute of Texas (CPRIT)
1R21CA227996/National Cancer Institute of the National Institutes of Health